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Abstract 
Optimal fetal lung growth requires anion-driven fluid secretion into the lumen of the 
developing organ. The fetus is hypercalcemic compared to the mother and here we show that 
in the developing human lung this hypercalcaemia acts on the extracellular calcium-sensing 
receptor, CaSR, to promote fluid-driven lung expansion through activation of the cystic fibrosis 
transmembrane conductance regulator, CFTR. Several chloride channels including TMEM16, 
bestrophin, CFTR, ClCN2 and ClCA1, are also expressed in the developing human fetal lung 
at gestational stages when CaSR expression is maximal. Measurements of Cl--driven fluid 
secretion in organ explant cultures show that pharmacological CaSR activation by 
calcimimetics stimulates lung fluid secretion through CFTR, an effect which in humans, but 
not mice, was also mimicked by fetal hypercalcemic conditions, demonstrating that the 
physiological relevance of such a mechanism appears to be species-specific. Calcimimetics 
promote CFTR opening by activating adenylate cyclase and we show that Ca2+-stimulated type 
I adenylate cyclase is expressed in the developing human lung. Together, these observations 
suggest that physiological fetal hypercalcemia, acting on the CaSR, promotes humans fetal 
lung development via cAMP-dependent opening of CFTR. Disturbances in this process would 
be expected to permanently impact lung structure and might predispose to certain postnatal 
respiratory diseases.  
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Introduction 
During gestation, the developing lung goes from a fluid-filled organ in the fetus to a fully 
formed, highly mature structure equipped for optimal gaseous exchange from the moment of 
birth 1-3. An impairment of the lung developmental programme in utero is at the basis of many 
respiratory diseases 3,4. Lung development is characterised by five developmental different 
stages: embryonic, pseudoglandular, canalicular, saccular and alveolar. At the end of the 
embryonic stage, the lung is almost a compact structure with very small intraluminal volume 
and poor compliance. During the pseudoglandular stage (E11.5 - 16.5 in mice, weeks 5 -17 in 
humans) there is a rapid expansion of the conducting airways when the developing lung 
undergoes stereotypic branching and budding 5, a process which is driven by fluid secreted into 
the lung lumen to generate the distending pressure required for normal expansion 6,7. Sustained 
reduction in lung expansion, such as that observed as a secondary consequence of failed closure 
of the diaphragm during fetal development leading to congenital diaphragmatic hernia8, 
contributes to fetal lung hypoplasia, which is highly associated with respiratory insufficiency 
at birth and respiratory distress syndrome during childhood 2. On the other hand, increasing the 
intraluminal hydrostatic pressure by tracheal occlusion leads to an increase in lung DNA and 
protein content and to lung hyperplasia 2,3,9,10.  Critical to the generation of the transpulmonary 
pressure gradient necessary for lung expansion is transepithelial Cl- transport 7,11-14 which, 
together with Na+ electrodiffusion, drives net water movement as a consequence of the osmotic 
pressure gradient 7.  
Fetal lung development occurs in a relatively hypercalcaemic environment. Free ionized 
extracellular calcium concentration ([Ca2+]o) in both the human and mice fetus is 
approximately 1.6 - 1.7 mM, compared to 1.1 - 1.3 mM in the adult 15. Recently, we have 
demonstrated that this relative fetal hypercalcaemia is necessary for optimal prenatal lung fluid 
secretion 10, an effect which is mediated by the extracellular calcium-sensing receptor (CaSR) 
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10,16
, a G protein-coupled receptor (GPCR) whose expression is developmentally regulated and 
confined to the prenatal mouse and human distal lungs 10,17,18. A number of different chloride 
channels have been shown to be expressed in fluid-secreting fetal alveolar epithelial cells 
including members of the chloride channel (CLC) family 19,20, the Ca2+-activated chloride 
channel TMEM16A 21,22, bestrophin-1 23 and the cystic fibrosis transmembrane conductance 
regulator (CFTR) 24, but the exact mechanism by which activation of the CaSR leads to 
chloride-driven fluid secretion in the fetal lung lumen is currently unknown 1.  
In this study, we sought to examine how activation of the CaSR leads to increased fluid 
secretion and lung growth within the developing human lung. Because much of the work aimed 
at testing the contribution of each Cl- channel to lung fluid secretion has been done using 
genetically modified mice, initially we compared the expression of a variety of chloride 
channels in the developing mouse and human fetal lungs using immunohistochemistry. 
Subsequently we investigated the effects of pharmacological (calcimimetics) and physiological 
(Ca2+o) CaSR activation on fluid secretion and identified the main Cl- channels responsible for 
this process in chemically-defined, serum-free whole mouse and human lung explant cultures. 
Finally, the signalling machinery involved in CaSR-driven fluid secretion was examined using 
live imaging in an in vitro cell reporter system.  
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Methods 
Ethical approval 
Wild type C57Bl/6 mice were housed conventionally with a 12 h light:dark cycle and had free 
access to food and water. All animal procedures were approved by the UK Home Office and 
carried out in the UK in accordance with the Animal (Scientific Procedures) Act 1986.  
Human fetal tissue was obtained from ethically-consented maternal donor medical termination 
at 7 - 11 week of pregnancy following the guidelines of the Polkinghorne and Department of 
Health reports with approval from South East Wales Research Ethics Committee 25,26. Upon 
consent for termination, full written consent for the tissue was obtained from the maternal 
donor as part of the Medical Research Council (UK)-sponsored South Wales Initiative for 
Transplantation (SWIFT) program. Gestational age was first assessed by ultrasound and 
confirmed using morphometric parameters after therapeutic abortion. 
Immunohistochemistry and immunofluorescence 
Human fetal (7 - 11 week post conception) or E12.5 mouse lungs were fixed in formalin 
overnight and subsequently embedded in paraffin. 5 µm thick sections were deparaffinised in 
xylene and rehydrated using a decreasing alcohol-water series (100%, 90%, 75% ethanol), 
followed by washing in distilled water. Fischer rat thyroid (FRT) cells stably transfected with 
CFTR were grown on sterilized glass coverslips of 13 mm diameter in 24 well plates. The 
culture medium was removed and the cells were fixed in 4 % (w/v) PFA in PBS for 15 minutes. 
The immunohistochemical protocol used was established and optimised for each species and 
antibody (see Table 1). Briefly, permeabilization with 1% SDS or heat-induced epitope 
retrieval was perform with either citrate buffer pH 6 or Tris/EDTA buffer, pH 9 to recover the 
antigenicity of the tissue. Endogenous peroxidase activity was quenched by incubating the 
6 
 
tissue with 1% hydrogen peroxide in methanol. Non-specific antibody binding was prevented 
by incubating the slides with blocking solution for 1 hour at room temperature. Primary 
antibodies were diluted in blocking solution and applied to slides overnight at 4 °C. Negative 
controls were carried out through substitution of the primary antibody with either rabbit or goat 
serum. Protein immunoreactivity was detected using a horseradish-peroxidase conjugated 
secondary antibody (Dako UK, Cambridgeshire, U.K.; 1:200) applied for 1 hour at room 
temperature. Antigen-antibody binding was visualized with diaminobenzidine (Sigma-
Aldrich), after which the slides were counterstained with haematoxylin. The slides were 
dehydrated using an increasing alcohol series (30s in 75% ethanol, 4 min in 100% ethanol) and 
finally cleared in xylene before being mounted using DPX mounting medium (Depex-
Polystyrene in xylene, Timstar laboratory Suppliers, Ltd, Marshfield Bank, U.K.). Slides were 
left to dry overnight and then photographed using a microscope attached to an Infinity 2-2C 
CCD camera (Lumenera, Ottawa, Canada) and/or scanned using a slide scanner (MIRAX 
SCAN, Carl Zeiss MicroImaging GmbH, Göttingen, Germany). 
5 µm thick, paraffin embedded week 10 human fetal lungs were dewaxed and rehydrated as 
described above. Samples for immunofluorescence were washed in 50 mM NH4Cl in PBS to 
quench free aldehyde groups remaining from the fixation step. Permeabilization and/or heat-
induced epitope retrieval was performed as described above. Non-specific antibody binding 
was prevented by incubating the slides with blocking solution for 1 hour at room temperature.  
Primary antibodies were diluted in blocking solution and applied to slides overnight at 4 °C. 
After washing in PBS, primary antibody binding was visualized using Alexa Fluor 594 
fluorescence-dye coupled secondary antibodies in blocking buffer. Nuclei were counterstained 
with Hoechst 34580. Coverslips with adhering cells were then mounted on standard glass slides 
using ProLong Gold® (Life Technologies), while human lung slide were mounted in DPX after 
dehydration. Negative controls were carried out through substitution of the primary antibody 
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with either rabbit or goat serum. Slides and cells were left to dry overnight and then 
epifluorescence images of immunostained tissues and cells were analysed and photographed 
with an Olympus BX61 automated microscope equipped with a 100 W high pressure mercury 
lamp, using AnalySIS software (Olympus Microscopy, Essex, U.K.). 
Lung explant culture 
Lungs explanted from 7 - 9 week human fetal tissue and E12.5 mice were cultured for 48 - 72 
hours according to previous published protocols 10,27-29. Human fetal lungs were separated into 
two halves with the trachea alternatively kept with the left or right lung in the same 
experimental series, a manoeuvre which did not affect lung growth. Timelapse images were 
captured at 0, 24, 48 and 72 hours with a dissecting microscope equipped with a digital camera 
(Leica Microsystems, Milton Keynes, U.K.). 
For the fetal Ca2+o conditions, [Ca2+]o in the DMEM-F12 medium was increased from 1.05 mM 
[Ca2+]o to 1.70 mM [Ca2+]o using 1 M CaCl2 (Sigma-Aldrich, Gillingham, U.K.). Inhibitors of 
chloride-transporting mechanisms included the wide-spectrum anion exchange inhibitor 4,4'-
Diisothiocyano-2,2'-stilbenedisulfonic acid (DIDS) (Sigma-Aldrich) and the CFTR specific 
inhibitor Inh-172 (Tocris) and the loop diuretic, bumetanide (Sigma-Aldrich). All chloride 
channel inhibitors were dissolved in DMSO, which has previously been shown to not to affect 
lung explant growth 10. Vehicle control experiments were performed by adding the equivalent 
amount of DMSO to the lung cultures.  
Measurements of lung fluid secretion  
Transepithelial electrical potential difference (PD), indicative of anion-driven fluid secretion 
into the lumen of the developing lung, was recorded as previously described 10 after 48 or after 
72 hours lung explant cultures for mouse and human lung, respectively. Briefly, lung explants 
attached to filters were placed in a recording chamber mounted on an Olympus CK41 inverted 
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microscope (Olympus, Southall, U.K.) and secured using a slice anchor (Warner Instruments, 
Hamden, CT, USA). The recording chamber was filled with a solution containing (in mM): 
135 NaCl, 5 KCl, 1.2 MgCl2, 1 CaCl2, 5 HEPES, 10 glucose, pH 7.45. A 2-3 MΩ borosilicate 
glass electrode (World Precision Instruments, Stevenage, U.K.) was filled with a solution 
containing a 0.4% trypan blue/0.85% saline solution (Invitrogen). Electrodes were slowly 
pushed into a terminal lumen whilst maintaining positive pressure, with the presence of trypan 
blue in the lumen being indicative of successful access to the lumen. Once access to the lumen 
had been achieved, positive pressure was immediately removed and the PD was recorded after 
a 5 min equilibration period. E12.5 mouse lungs were cultured for 48 h in the presence of 1.05 
mM or 1.70 mM Ca2+o in the presence or absence of the wide-spectrum anion exchange 
inhibitor which blocks Ca2+-activated chloride channels including TMEM16A and bestrophin, 
4,4'-Diisothiocyano-2,2'-stilbenedisulfonic acid (DIDS) 1,30,31, of the loop diuretic bumetanide, 
or of the selective CFTR inhibitor (Inh-172). Unless stated otherwise, transepithelial PD 
measurements were expressed as percentage of 1.05 mM Ca2+o control.  
Measurements of CFTR activation using a halide-sensitive reporter system 
CaSR-dependent activation of CFTR was measured by single cell imaging of Fischer rat 
thyroid (FRT) cells stably transfected with the human CFTR channel and a halide sensitive 
YFP (YFP-H148). The FRT-CFTR-YFP cell line has previously been used for high-throughput 
screening for the identification of CFTR modulators 32.  
FRT-CFTR-YFP cells were maintained in Coon’s modification of F12 (Sigma-Aldrich) 
supplemented with sodium bicarbonate (3.2 mM), 2 mM glutamine, 100 U/mL penicillin, 100 
µg/mL streptomycin and 10% fetal bovine serum (Invitrogen). Cells were plated on to 13 mm 
glass coverslips 48 h before being placed in the light path of an inverted microscope (Olympus 
9 
 
IX71, Southend-on-Sea, U.K.). A Xenon arc fluorescence light source was used to excite the 
intracellular YFP at 470 nm and visualise emission at 520 nm.  
Cells were equilibrated using standard Dulbecco’s PBS (137 mM NaCl, 2.7 mM KCl, 8.1 mM 
Na2HPO4, 1.5 mM KH2PO4, 1mM CaCl2 and 0.5 mM MgCl2, pH 7.4) in presence of 
pharmacological agents including the adenylate cyclase activator forskolin (20 µM), the 
specific CaSR allosteric activator NPS-R568 (1 µM), the CFTR inhibitor Inh-172 (10 µM) and 
the adenylate cyclase inhibitor MDL-12330A (25 µM). During the experiments cells were pre-
incubated with Dulbecco’s PBS in the presence and absence of various activators and inhibitors 
for at least 5 min before being perfused with Iodide-rich Dulbecco’s PBS (137 mM NaI, 2.7 
mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, 1mM CaCl2 and 0.5 mM MgCl2, pH 7.4) while 
YFP fluorescence was imaged. Iodide influx quenches the cells YFP fluorescence with a rate 
that is dependent on the halide permeability of the cell, and therefore on the activity of the 
CFTR channel. Quenching rates were calculated by fitting the YFP fluorescence decay with a 
one-phase exponential decay function using GraphPad Prism 6.01 (GraphPad Software, La 
Jolla, CA, USA). 
Data analysis and statistics 
Data are expressed as mean ± SEM. Significance was determined using a Student’s t test or 
one-way ANOVA with Tukey’s post-test. Statistical analyses were run in GraphPad Prism 6.01 
and observations were deemed to be significantly different for p value < 0.05.   
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Results 
Expression of Cl- channels in the developing mouse and human fetal lungs 
Our previous studies have demonstrated that CaSR expression is developmentally regulated in 
the fetal mouse and human lung, with expression peaking at around E12.5 - 13.5 for the mouse 
and weeks 8 - 11 in humans, during the pseudoglandular stage of lung development 10,18.  
We have also shown previously that, in intact mouse pseudoglandular lungs, CaSR activation 
leads to Cl--driven fluid secretion by unknown mechanisms10. However, the relevance of these 
findings to human lung development and the molecular mechanisms underpinning this process 
are unknown. To answer these queries, we investigated the expression of key Cl- channels 
putatively involved in anion-driven fluid secretion in the developing mouse and human lung in 
vivo during gestational stages of maximal CaSR expression.  
Immunohistochemistry carried out on serial sections of E12.5 mouse (Figure 1, left panels) and 
in human (Figure 1, right panels) fetal lungs at 9 - 11 week gestation demonstrated that in both 
species the airway epithelium expresses the Ca2+-regulated Cl- secretory channels, anoctamin-
1/transmembrane member 16A (TMEM16A), bestrophin-1 and the cystic fibrosis 
transmembrane conductance regulator (CFTR). TMEM16A expression was detected apically 
in mouse fetal lungs (Fig 1, left panel, block arrow) while in human fetal lungs TMEM16A 
appeared to be expressed predominantly at the basolateral domain of the pulmonary airways 
(Figure 1, arrowhead) although modest staining was observed apically in small airways (Figure 
1, block arrow).  
Bestrophin-1 expression was detected apically in the airway epithelia of mouse and human 
fetal lungs (Figure 1, middle panels, block arrow). In the human lung, bestrophin-1 was also 
expressed in a sub-population of cells in the mesenchyme. Based on their arrangement and 
elongated appearance, these appear to be smooth muscles cells (Figure 1, open arrow). 
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Strong apical CFTR expression was found in the developing mouse pulmonary airways (Figure 
1, bottom left panel, block arrow). Consistent with previous findings in human fetal lungs 24,33, 
CFTR immunoreactivity was found apically and basolaterally in the pulmonary airways of 
human fetal lung at 10 week gestation (Figure 1, bottom right panel, arrowhead). CFTR was 
also found in a discrete population of cells encircling the primitive lumen. These cells may be 
airway smooth muscle cells according to their arrangement and appearance, which is flattened 
and elongated (Figure 1, left panel, open arrow). For all the antibodies tested negative controls, 
performed in serial sections, yielded no signals, as shown in the insets. 
In the developing lung, basolateral Cl- entry is mediated largely via the Na+/K+/2Cl- co-
transporter 1, NKCC131,32, and indeed NKCC1 immunoreactivity was found at the basolateral 
side of the developing mouse and human lung (Figure S1) 34,35 34,35. In humans, NKCC1 
immunoreactivity was detected in the columnar and cuboid epithelial cells lining the smaller 
airways. Furthermore, NKCC1 was present in the mesenchyme cells surrounding the human 
developing airways. Together, these results indicate that, in both human and mouse, bestrophin 
and/or CFTR are the most likely candidates for apical Cl--driven fluid secretion. TMEM16A 
could also contribute to this process in the developing mouse, but not in the human lung.  
The apical Cl- channels, TMEM16A and bestrophin-1, do not contribute to 
Ca2+o-stimulated lung fluid secretion in the mouse fetal lung 
To elucidate which mechanisms are involved in CaSR-mediated fluid secretion, we measured 
transepithelial potential difference (PD) as a surrogate for anion-driven fluid secretion. Thus, 
E12.5 mouse lungs were cultured in the presence of blockers of those Cl- channels found to be 
expressed at the apical membrane of lung lumen epithelial cells of the developing mouse lung, 
namely TMEM16A and bestrophin-1. Lungs cultured for 48 hours in the presence of medium 
containing 1.05 mM Ca2+o in the absence or presence of DIDS (100 µM) appeared to be 
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comparable in morphology and transepithelial PD (Figure S2, 100 ± 44 % in control conditions, 
95 ± 27% in the presence of DIDS, n = 5 - 11, ns, one-way ANOVA, Tukey’s post-test). 
Culturing E12.5 mouse lungs for 48 hours in the presence of medium containing 1.70 mM 
Ca2+o led to an increase in transepithelial PD to 181 ± 29% (Figure S2, n = 6, p < 0.01 vs. 1.05 
mM Ca2+o control). DIDS did not significantly alter the transepithelial PD when added to 
medium containing 1.70 mM Ca2+o (Figure S2, 225 ± 43%, n = 6, not significant (n.s.), p > 
0.05). Figure S2 also shows that DIDS did not affect fluid secretion of mouse lungs cultured in 
the presence of ether 1.05 mM Ca2+o or 1.70 mM Ca2+o. This result suggests that neither 
TMEM16A nor bestrophin-1 significantly contribute to Ca2+o -stimulated fetal mouse lung 
fluid secretion. 
Furthermore, we tested the contribution that CaSR makes to the regulation of basolateral Cl- 
entry by measuring transpetithelial PD in lungs cultured in the presence of the loop diuretic 
bumetanide, an NKCC1 blocker.  Lungs cultured in medium containing 1.05 mM Ca2+o showed 
a decrease in luminal PD to increasing concentrations of bumetanide, with luminal PD reduced 
by ~50% compared to 1.05 mM Ca2+o alone (Figure S3 n = 16 - 23, p<0.001). Similar to that 
which we have reported previously 10, culturing E12.5 lung in medium containing fetal Ca2+o 
concentrations (i.e., 1.70 mM) increased transepithelial PD compared to lungs cultured in the 
presence of medium containing 1.05 mM Ca2+o control (Figure S3, 124 ± 13 % vs. 100 ± 15%, 
n = 23 - 29, p<0.001). Culturing these lungs in the presence of bumetanide (30 µM) led to 
decreases in luminal PD to ~ 75% of the 1.70 mM Ca2+o control (92 ± 10 % vs. 124 ± 13%, n 
= 17 - 29, p<0.001). These results suggest that basolateral Cl- entry is not regulated by 
CaSR/Ca2+o. 
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CFTR mediates CaSR-induced fluid secretion in the mouse and human fetal 
lung 
The expression studies reported previously suggest that CFTR might be involved in CaSR-
stimulated apical Cl--secretion. To test this hypothesis further, we performed 
electrophysiological recordings of mouse and human lung explant cultures in the presence or 
absence of the specific CaSR allosteric activator 36, NPS-R568, with or without the CFTR 
inhibitor, Inh-172. Culturing E12.5 mouse lungs for 48h in the presence of low (i.e., 1.05 mM) 
Ca2+o medium containing NPS-R568 (10nM) led to a significant increase in transluminal PD 
from 100 ± 13% (n = 9) to 184 ± 19% (Figure 2A; n = 9, p < 0.01). Addition of the CFTR 
inhibitor Inh-172 (10 µM)37 significantly blocked this increase (Figure 2A; 86 ± 17%, n = 9, p 
< 0.001). These results suggest that, in mouse lungs, CaSR promotes fluid secretion via 
activation of CFTR.  
To examine whether, in the developing human lung, activation of the CaSR is also involved in 
this Ca2+o-driven fluid secretion via activation of CFTR, we performed two sets of paired 
experiments using right and left lobes of the same lungs and compared 1.05 mM Ca2+o vs. 1.05 
mM Ca2+o + 100 nM R568 (to test for CaSR-mediated activation of fluid secretion); and another 
comparing 1.05 mM Ca2+o + 100 nM R568 vs. 1.05 mM Ca2+o + 100 nM R568 + 10 µM Inh-
172 (to test for CFTR-dependent CaSR-mediated activation of fluid secretion). In both sets of 
experiments, transepithelial PD was normalised against the 1.05 mM Ca2+o + 100 nM R568 
condition. Human lung rudiments cultured in medium containing 1.05 mM Ca2+o showed 
significantly reduced transepithelial PD compared to those cultured in 1.05 mM Ca2+o + 100 
nM R568 (Figure 2B, 56 ± 10% vs. 100% (n = 4), p < 0.05) indicative that pharmacological 
CaSR activation almost doubled Cl- fluid secretion also in the human fetal lung. This CaSR-
mediated increases in transluminal PD was blunted in the presence of Inh-172 (Figure 2B, 
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100% vs 68 ± 9%, p < 0.05), confirming that CaSR activation induces an increase in fluid 
secretion via activation of CFTR in human fetal lung. Immunofluorescence microscopy of 
pseudoglandular human fetal lung sections revealed that both CaSR and CFTR were co-
expressed at the apical membrane of the bronchial epithelium, suggesting the possibility of a 
close functional interaction between these two proteins (Figure 2C).  
Physiological fetal hypercalcemia activates the CaSR leading to an increase in 
CFTR-driven fluid secretion in the human, but not in the mouse fetal lung  
The fetus is relatively hypercalcemic compared to the mother, reaching Ca2+o concentrations 
of ~1.7 mM, at which the CaSR is maximally active and that would lead to CaSR-mediated 
CFTR activation during developmental periods in development when the receptor is expressed. 
To test directly the hypothesis that fetal hypercalcemia, acting on the CaSR, provides a 
physiological stimulus for lung fluid secretion, we cultured E12.5 mouse lungs for 48 hours in 
medium containing either 1.05 mM or 1.70 mM Ca2+o in presence or absence of Inh-172 (10 
µM), before measurements of transepithelial PD were conducted. Lungs cultured for 48 hours 
in medium containing 1.70 mM Ca2+o exhibited the expected increase in luminal PD to 221 ± 
17% (Figure 3A, n = 9, p < 0.05). However the addition of Inh-172 did not inhibit Ca2+o-
mediated changes in transepithelial PD (Figure 3A, 217 ± 38%, n = 10, n.s., p  > 0.05). In 
paired human fetal lungs (i.e., one lung per condition from the same donor), lung rudiments 
cultured in medium containing 1.05 mM Ca2+o showed a reduced transepithelial PD compared 
to 1.70 mM Ca2+o (Figure 3B, 40 ± 5% vs 100 (n = 4), p < 0.01). However, in stark contrast to 
what we observed in mouse, the addition of Inh-172 blocked this increase, as evidence by the 
drop in transepithelial PD from 100 to 50 ± % (Figure 3B, n = 19, p < 0.001). Together, these 
results suggest that physiological fetal hypercalcemia stimulates fluid secretion via the CaSR 
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in the developing human lung, a process which does not occur in the developing mouse lung, 
where hypercalcaemia drives anion-driven fluid secretion through channels other than CFTR.  
 
CaSR-mediated activation of CFTR requires adenylate cyclase 
Having ascertained that, in the human fetal lung, CaSR and CFTR are functionally coupled, 
we investigated further the cellular mechanisms underpinning CaSR-mediated CFTR 
activation using an in vitro system previously used in high-throughput screening for 
identification of CFTR modulators32. Specifically, Fischer Rat Thyroid (FRT) cells, which here 
show to express endogenously the CaSR (Figure 4A) were stably transfected with human 
CFTR and a halide-sensitive YFP probe (FRT-CFTR-hsYFP). Perfusion of iodide-rich PBS 
across FRT-CFTR-hsYFP cells led to a slight quenching of YFP fluorescence during the first 
three minutes due to the inherent halide permeability of the cell at a rate of k = 0.42 ± 0.02 
(Figure 4B, Table 2, N = 7, n =197). When FRT cells were pre-incubated with forskolin to 
evoke an increase in intracellular cAMP levels 38, a stimulus known to open CFTR 32 (thereby 
acting as a positive control) the introduction of the iodide-rich DPBS led to a sharp decrease in 
YFP fluorescence at a rate of k = 1.76 ± 0.05 to 46 ± 2% (Figure 4B, Table 2, N = 10, n = 150, 
rate: p < 0.001 vs. time control), indicating that the opening of CFTR led to an increase in the 
halide permeability of the FRT-CFTR-hsYFP cells.  
To examine the effect of pharmacological CaSR activation on CFTR, FRT-CFTR-hsYFP cells 
were pre-incubated with the calcimimetic NPS R-568 (1 µM) before addition of the iodide-rich 
PBS. Pre-incubation with NPS R-568 led to a significant increase in the rate of YFP quenching 
compared to control, quenching YFP fluorescence to 61 ± 3% at a rate constant of k = 1.31 ± 
0.03 (Figure 4B, Table 2, rate: p < 0.001 vs. time control, N = 9, n = 168). Next, we determined 
whether this CaSR-mediated increase in halide permeability was due to opening of  CFTR by 
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pre-incubating the cells with NPS-R568 + Inh-172. This manoeuvre prevented CaSR-mediated 
activation of CFTR (Figure 4B, Table 2, k = 0.42 ± 0.03, p < 0.001 vs. 1 µM NPS-R568, n.s. 
vs. time control, N = 8, n = 132). Similarly, cell pre-incubation with medium containing NPS-
R568 + MDL-12330A, a pan-inhibitor of adenylate cyclase, also significantly reduced YFP 
quenching rates (Figure 4B, Table 2, k = 0.56 ± 0.05, p < 0.001 vs 1 µM NPS-R568, N = 6, n 
= 93), demonstrating that the CaSR-mediated activation of CFTR requires activation of 
adenylate cyclase. 
Classically CFTR is activated by cyclic AMP (cAMP)-dependent activation of protein kinase 
A (PKA). However, intracellular calcium ion (Ca2+i)-mobilising agonists are known to couple 
to Ca2+-activated chloride channels39. However, recently Ca2+i-mobilising agonists activate 
CFTR by a mechanism involving Ca2+i-dependent activation of adenylyl cyclase I (AC1) and 
cAMP/PKA signaling in human bronchial epithelial cells39. We have previously demonstrated 
in the developing mouse lung that CaSR activation leads to Ca2+i mobilisation 10 and therefore 
suggest that, in the human fetal lung, AC1 could also be involved in CaSR-mediated activation 
of CFTR. Indeed, AC1 is expressed within the columnar and cuboidal epithelial cells of the 
human fetal lung (Figure S4). Therefore, CaSR activation, which yields an increase in Ca2+i, 
would be expected to activate AC1, an effect which would result in opening of CFTR.  
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Discussion 
Fluid secretion into the lumen of the fetal lung is essential for optimal lung development as it 
provides the mechanical stress necessary for lung expansion, cell division and tissue 
remodelling 7,40. Defective fluid secretion in the fetal lung leads to drastic changes in the 
developing organ structure 3, with decreases in fluid secretion leading to hypoplastic lungs 
accompanied by alterations in lung morphology, whilst excessive fluid secretion produces 
hyperplastic and over-distended fetal lungs 41,42, both of which are associated with long-lasting 
morbidity 3. Previously, we have shown that physiological fetal hypercalcemia is an important 
environmental cue regulating many aspects of lung development 10. Here we demonstrate that 
fetal hypercalcemia, acting through the CaSR, promotes human fetal lung growth and 
expansion via CFTR.  
Apical Cl- secretion results as a consequence of transepithelial Cl- movements mediated by 
basolateral entry, raising its intracellular concentration above equilibrium facilitating its 
luminal exit through apical chloride channels 43, in addition to isoosmotic transport of water 7. 
Basolateral Cl- entry occurs via NKCC1 7,44 and inhibition of NKCC1 by the loop diuretic 
bumetanide inhibits lung liquid secretion in distal lung explants, an effect not seen in NKCC1 
knockout mice 35. Our study shows that NKCC1 is expressed on the basolateral membrane of 
columnar and cuboid epithelial cells in both developing mouse and human lungs and that, while 
bumetanide inhibited fetal lung fluid secretion by approximately 50%, this effect was 
insensitive to changes in Ca2+o concentration, suggesting that this process is constitutively 
active and not regulated by the CaSR. 
Our immunohistochemical observations indicate that apical Cl- exit might be facilitated by 
TMEM16A, bestrophin-1 and CFTR in the developing mouse and human fetal lung. Additional 
channels and associated proteins involved in mediated calcium-activated chloride conductance 
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- CLCN2 and CLCA1 - are also expressed in the developing human fetal lung at the basolateral 
membrane of epithelial cells and, as such, not likely to contribute directly to apical Cl- exit 
(Figure S5).  
Previous studies have suggested that TMEM16A and bestrophin-1 may play important roles in 
generating the baseline fluid secretion 22,23,45. However, the presence of DIDS in the growth 
medium had no effect on Ca2+o-mediated increases in fluid secretion suggesting that 
TMEM16A and bestrophin-1, as well as other DIDS sensitive Cl- channels, do not appear to 
be involved in Ca2+o-activated fluid secretion.  
These observations led us to conclude that CFTR is the primary apical Cl- channel candidate 
functionally coupled to the CaSR. A role for CFTR in fetal lung development has been 
questioned because of conflicting findings between observations carried out in human and 
mouse lungs. On one hand, CFTR-/- mice are born with apparently normal lungs 46, suggesting 
either that CFTR plays no role in fetal lung fluid secretion or that there is functional 
redundancy. On the other hand, accumulating evidence in humans suggests that lungs of new-
borns with cystic fibrosis (CF), an autosomal recessive disease caused by mutations leading to 
an inactive CFTR, have a number of functional and structural abnormalities 47,48. These 
observations are consistent with the species differences seen in the current study. Of note, in 
humans CaSR and CFTR expression are developmentally regulated, both showing strongest 
expression within the pulmonary epithelium during the pseudoglandular stage of development 
18,49,50
, the period critical for the formation of the conductive airways, corroborating the idea 
that the stimulatory role of the CaSR on fluid secretion could, indeed, be mediated by CFTR.  
CFTR is insensitive to DIDS 51. Therefore, we examined the effect of a specific CFTR inhibitor 
on CaSR-mediated fluid secretion in both human and mouse fetal lungs. The presence of Inh-
172 in the growth medium suppressed increases in human and mouse fetal lung fluid secretion 
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due to pharmacological CaSR activation. In human fetal lungs Inh-172 also suppressed Ca2+o-
mediated increases in fluid secretion, suggestive that CaSR regulation of CFTR is the primary 
mechanism driving Ca2+o-mediated increase in fetal lung fluid secretion in humans. 
Importantly, inhibition of CFTR had no effect on Ca2+o-mediated increases in fluid secretion 
in the mouse fetal lung, suggestive that an alternative mechanism could account for Ca2+o-
sensitive fluid secretion in mice, which could account for the species-dependent gating 
behaviour in murine and human CFTR52,53.  
Conventionally CFTR is activated by cAMP and PKA whereas Ca2+-activated chloride 
channels are activated by Ca2+i-mobilising agonists like UTP. Furthermore, classical CaSR 
signalling is preferentially coupled to Gαi leading to a decrease in intracellular cAMP 54, which 
seems at odds with our finding that activation of CaSR leads to activation of CFTR55. Using 
co-immunoprecipitation pull-downs we found no evidence that the CaSR and CFTR have a 
biochemical interaction in either E12.5 mouse or 8 week human fetal lungs (data not shown). 
However, pharmacological approaches demonstrated that the calcimimetic NPS R-568 induced 
opening of CFTR that was dependent on adenylate cyclase. Of the nine G-protein–responsive 
transmembrane adenylyl cyclase (AC1-9) isoforms identified, AC1 can be stimulated by 
Ca2+i/calmodulin in contrast to many other ACs, which are either Ca2+-insensitive or Ca2+-
inhibited. In addition, Namkung et al. have showed that, in human bronchial cells, the Ca2+i 
mobilising agonist, UTP, can stimulate CFTR opening through AC1 39. In conjunction with our 
previous findings in fetal mouse epithelial buds 10 that activation of the CaSR leads to Ca2+i 
mobilisation, we propose that, in the developing human lung epithelium, CaSR activation by 
NPS R-568 and/or fetal hypercalcemia leads to an increase in Ca2+i, attendant activation of 
AC1 and opening of CFTR. A potentially similar mechanism has been described in duodenal 
epithelial cells, where CaSR agonists induce bicarbonate secretion via CFTR, through 
activation of PLC and increase in Ca2+i 56.  
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Newborns with CF were long considered to be born with normal lungs 57, with progressive 
structural abnormalities developing later 48, suggestive that CFTR does not play a crucial role 
in lung developmental process. However, more recent studies have demonstrated that transient 
in utero disruption of CFTR leads to progressive changes in lung function and structure that 
appear to predispose to adult lung disease 58,59, possibly due to interference in stretch-induced 
differentiation through inflammatory expression changes in smooth muscles proteins and/or 
the effects of a constitutive inflammatory process 58,60,61. On the basis of our current findings, 
we suggest that mutations, which affect expression and/or function of CFTR, would lead to a 
reduction of increases in fluid secretion induced by fetal hypercalcemia via CaSR activation. 
In addition, respiratory problems, such as chronic and interstitial lung disease and reduction in 
gas exchange, observed in some patients with inactivating or activating mutations of the CaSR 
62-66
 could also be caused by altered fluid secretion in the developing lung, which permanently 
compromises lung morphology and structure.  
In conclusion, we have demonstrated that during the pseudoglandular stage of lung 
development fetal hypercalcemia of a magnitude similar to that seen physiologically in the 
prenatal period activates the CaSR leads to an increase in Ca2+i, which in turn activates the 
Ca2+-stimulated AC1, inducing opening of CFTR within the apical membrane of the 
developing pulmonary epithelium (Figure 5). This does not occur in mice, which goes some 
way to explaining why human CF patients demonstrate persistent lung growth and 
developmental abnormalities while CFTR null mice do not. Finally, lung hypoplasia can result 
as a consequence of a wide variety of aetiologies. As catch up growth does not occur and 
damage to the lung developmental programme is permanent, stunted lung development is 
associated with long-lasting, deleterious effects and may predispose to many respiratory 
diseases. While fetal endoscopic tracheal occlusion has been used to reverse lung growth 
deficits2, it is only recommended in the most severe cases67, and shows partial success. Owing 
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to their ability to promote CaSR-driven fluid secretion in the developing human lung, locally 
delivered calcimimetics could be used to increase the transmural pressure gradient and 
therefore offer the potential to rescue impaired growth in hypoplastic lungs in utero. 
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Table 1: Summary of primary antibody concentration, antigen retrieval solution and blocking solution for each protein. 
 
Primary 
Antibody 
Antibody 
Concentration 
Antigen 
Retrieval 
Blocking 
Solution/ 
Antibody 
dilution 
Secondary Antibody Company 
CFTR 
Polyclonal rabbit 
CFTR 
(ab59394) 
Mouse (1:200) 
Human (1:200) Citrate Buffer 
3% NGS + 1% 
BSA 
Goat anti-rabbit  
IgG-HRP 
(P0448) 
Abcam 
TMEM16A 
Polyclonal rabbit 
TMEM16A 
(ab53212) 
Mouse (1:200) 
Human (1:200) Tris/EDTA 
5% Seablock + 
1% BSA 
Bestrophin-1 
Polyclonal rabbit 
human Bestrophin 
(ab14927) 
Mouse (1:200) 
Human (1:200) Tris/EDTA 
5% Seablock + 
1% BSA 
CaSR 
Monoclonal 
mouse CaSR 
(ab19347) 
Human (1:200) 
FRT cells (1:100) Citrate Buffer 
5% Seablock in 
PBS 
Rabbit anti-mouse  
IgG-HRP 
(P0260) 
IgG - Alex594 
(A-11032) 
Adenylate 
Cyclase 1 
Polyclonal rabbit 
AC1  
(ac38331) 
Human fetal lung 
(1:200) Citrate buffer 
5% Seablock in 
PBS 
Goat anti-rabbit  
IgG-HRP 
NKCC 
Polyclonal goat 
NKCC1  
(sc21545) 
Mouse (1:200) 
Human (1:50) Tris/EDTA 
5% Seablock in 
PBS 
Donkey anti-goat  
IgG-HRP 
(sc2020) 
Santa-Cruz 
Biotechnology CLCA1 
Polyclonal rabbit 
CLCA1 
(sc67157) 
Human (1:300) 1% SDS 5% Seablock in PBS Goat anti-rabbit  
IgG-HRP 
CLCN2 
Polyclonal rabbit 
CLCN2 antibody 
(ab49883) 
Human (1:200) Tris/EDTA 
 
5% Seablock + 
1% BSA 
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Table 2: Rate of YFP Quenching and Quenching (%) for FRT-CFTR-hsYFP cells 
 
 
Rate of 
Quenching 
(k) 
Significance 
vs Control 
Significance 
vs NPS-
R568 
Quench 
after 
5 min (%) 
Significance 
vs Control 
Significance 
vs NPS-
R568 
 
Control 0.42 ± 0.02   78 ± 3   N = 7, n =197 
1 µM NPS-R568 1.31 ± 0.03 p < 0.001  61 ± 3 p < 0.001  N = 9, n = 168 
1 µM NPS-R568 
+ 10 µM Inh-172 0.42 ± 0.03 NS p < 0.001 83 ± 1 NS p < 0.01 N = 8 , n = 132 
1 µM NPS-R568 
+ 25 µM MDL-12330A 0.56 ± 0.05 p < 0.001 p < 0.001 78 ± 3 NS p < 0.01 N = 6, n = 93 
20 µM Forskolin 1.76 ± 0.05 p < 0.001 p < 0.001 46 ± 2 p < 0.001 p < 0.001 N = 10, n = 150 
24 
 
References 
1 Warburton, D. et al. Molecular mechanisms of early lung specification 
and branching morphogenesis. Pediatr Res 57, 26R-37R, 
doi:10.1203/01.PDR.0000159570.01327.ED (2005). 
2 Harding, R. & Hooper, S. B. Regulation of lung expansion and lung 
growth before birth. J Appl Physiol (1985) 81, 209-224 (1996). 
3 Warburton, D. et al. Lung organogenesis. Curr Top Dev Biol 90, 73-158, 
doi:10.1016/s0070-2153(10)90003-3 (2010). 
4 Souza, P., Obrodovich, H. & Post, M. Lung Fluid Restriction Affects 
Growth but Not Airway Branching of Embryonic Rat Lung. Int J Dev 
Biol 39, 629-637 (1995). 
5 Whitsett, J. A., Wert, S. E. & Trapnell, B. C. Genetic disorders influencing 
lung formation and function at birth. Hum Mol Genet 13 Spec No 2, 
R207-215, doi:10.1093/hmg/ddh252 (2004). 
6 Alcorn, D. et al. Morphological effects of chronic tracheal ligation and 
drainage in the fetal lamb lung. J Anat 123, 649-660 (1977). 
7 Olver, R. E. & Strang, L. B. Ion fluxes across the pulmonary epithelium 
and the secretion of lung liquid in the foetal lamb. J Physiol 241, 327-
357 (1974). 
8 Butler, N. & Claireaux, A. E. Congenital diaphragmatic hernia as a cause 
of perinatal mortality. Lancet 1, 659-663 (1962). 
9 Fewell, J. E. & Johnson, P. Upper airway dynamics during breathing and 
during apnoea in fetal lambs. J Physiol 339, 495-504 (1983). 
10 Finney, B. A. et al. Regulation of mouse lung development by the 
extracellular calcium-sensing receptor, CaR. J Physiol 586, 6007-6019, 
doi:10.1113/jphysiol.2008.161687 (2008). 
11 Zeitlin, P. L., Loughlin, G. M. & Guggino, W. B. Ion transport in cultured 
fetal and adult rabbit tracheal epithelia. Am J Physiol 254, C691-698 
(1988). 
12 McCray, P. B., Jr. & Welsh, M. J. Developing fetal alveolar epithelial cells 
secrete fluid in primary culture. Am J Physiol 260, L494-500 (1991). 
13 Gatzy, J. T. Mode of chloride secretion by lung epithelia. Am Rev Respir 
Dis 127, S14-16 (1983). 
14 Olver, R. E., Walters, D. V. & S, M. W. Developmental regulation of lung 
liquid transport. Annu Rev Physiol 66, 77-101, 
doi:10.1146/annurev.physiol.66.071702.145229 (2004). 
15 Kovacs, C. S. & Kronenberg, H. M. Maternal-fetal calcium and bone 
metabolism during pregnancy, puerperium, and lactation. Endocr Rev 
18, 832-872 (1997). 
25 
 
16 Finney, B. et al. An exon 5-less splice variant of the extracellular 
calcium-sensing receptor rescues absence of the full-length receptor 
in the developing mouse lung. Exp Lung Res 37, 269-278, 
doi:10.3109/01902148.2010.545471 (2011). 
17 Brown, E. M. et al. Cloning and characterization of an extracellular 
Ca(2+)-sensing receptor from bovine parathyroid. Nature 366, 575-
580, doi:10.1038/366575a0 (1993). 
18 Riccardi, D. & Kemp, P. J. The calcium-sensing receptor beyond 
extracellular calcium homeostasis: conception, development, adult 
physiology, and disease. Annu Rev Physiol 74, 271-297, 
doi:10.1146/annurev-physiol-020911-153318 (2012). 
19 Blaisdell, C. J. et al. Inhibition of CLC-2 chloride channel expression 
interrupts expansion of fetal lung cysts. Am J Physiol Lung Cell Mol 
Physiol 286, L420-426, doi:10.1152/ajplung.00113.2003 (2004). 
20 Murray, C. B. et al. CIC-2: a developmentally dependent chloride 
channel expressed in the fetal lung and downregulated after birth. Am 
J Respir Cell Mol Biol 12, 597-604, doi:10.1165/ajrcmb.12.6.7766424 
(1995). 
21 Rock, J. R. & Harfe, B. D. Expression of TMEM16 paralogs during 
murine embryogenesis. Dev Dyn 237, 2566-2574, 
doi:10.1002/dvdy.21676 (2008). 
22 Rock, J. R., Futtner, C. R. & Harfe, B. D. The transmembrane protein 
TMEM16A is required for normal development of the murine trachea. 
Dev Biol 321, 141-149, doi:10.1016/j.ydbio.2008.06.009 (2008). 
23 Clin Exp ImmunolBarro-Soria, R., Schreiber, R. & Kunzelmann, K. 
Bestrophin 1 and 2 are components of the Ca(2+) activated Cl(-) 
conductance in mouse airways. Biochim Biophys Acta 1783, 1993-
2000, doi:10.1016/j.bbamcr.2008.06.016 (2008). 
24 McCray, P. B., Jr., Bettencourt, J. D., Bastacky, J., Denning, G. M. & Welsh, 
M. J. Expression of CFTR and a cAMP-stimulated chloride secretory 
current in cultured human fetal alveolar epithelial cells. Am J Respir 
Cell Mol Biol 9, 578-585, doi:10.1165/ajrcmb/9.6.578 (1993). 
25 Department of Health.     (Department of Health, London, UK, 1995). 
26 Polkinghorne, J.     (Her Majesty's Stationary Office, London, UK, 1989). 
27 De Langhe, S. P. et al. Dickkopf-1 (DKK1) reveals that fibronectin is a 
major target of Wnt signaling in branching morphogenesis of the 
mouse embryonic lung. Dev Biol 277, 316-331, 
doi:10.1016/j.ydbio.2004.09.023 (2005). 
28 Del Moral, P. M. et al. VEGF-A signaling through Flk-1 is a critical 
facilitator of early embryonic lung epithelial to endothelial crosstalk 
and branching morphogenesis. Dev Biol 290, 177-188, 
doi:10.1016/j.ydbio.2005.11.022 (2006). 
26 
 
29 Del Moral, P. M. & Warburton, D. Explant culture of mouse embryonic 
whole lung, isolated epithelium, or mesenchyme under chemically 
defined conditions as a system to evaluate the molecular mechanism 
of branching morphogenesis and cellular differentiation. Methods Mol 
Biol 633, 71-79, doi:10.1007/978-1-59745-019-5_5 (2010). 
30 Duran, C., Thompson, C. H., Xiao, Q. & Hartzell, H. C. Chloride channels: 
often enigmatic, rarely predictable. Annu Rev Physiol 72, 95-121, 
doi:10.1146/annurev-physiol-021909-135811 (2010). 
31 Liu, Y. et al. Characterization of the effects of Cl(-) channel modulators 
on TMEM16A and bestrophin-1 Ca(2+) activated Cl (-) channels. 
Pflugers Arch 467, 1417-1430, doi:10.1007/s00424-014-1572-5 
(2015). 
32 Pedemonte, N., Zegarra-Moran, O. & Galietta, L. J. High-throughput 
screening of libraries of compounds to identify CFTR modulators. 
Methods Mol Biol 741, 13-21, doi:10.1007/978-1-61779-117-8_2 
(2011). 
33 Marcorelles, P., Montier, T., Gillet, D., Lagarde, N. & Ferec, C. Evolution 
of CFTR protein distribution in lung tissue from normal and CF human 
fetuses. Pediatr Pulmonol 42, 1032-1040, doi:10.1002/ppul.20690 
(2007). 
34 Thom, J. & Perks, A. M. The effects of furosemide and bumetanide on 
lung liquid production by in vitro lungs from fetal guinea pigs. Can J 
Physiol Pharmacol 68, 1131-1135 (1990). 
35 Gillie, D. J., Pace, A. J., Coakley, R. J., Koller, B. H. & Barker, P. M. Liquid 
and ion transport by fetal airway and lung epithelia of mice deficient 
in sodium-potassium-2-chloride transporter. Am J Respir Cell Mol Biol 
25, 14-20, doi:10.1165/ajrcmb.25.1.4500 (2001). 
36 Nemeth, E. F. et al. Calcimimetics with potent and selective activity on 
the parathyroid calcium receptor. Proc Natl Acad Sci U S A 95, 4040-
4045 (1998). 
37 Ma, T. et al. Thiazolidinone CFTR inhibitor identified by high-
throughput screening blocks cholera toxin-induced intestinal fluid 
secretion. J Clin Invest 110, 1651-1658, doi:10.1172/JCI16112 (2002). 
38 de Souza, N. J., Dohadwalla, A. N. & Reden, J. Forskolin: a labdane 
diterpenoid with antihypertensive, positive inotropic, platelet 
aggregation inhibitory, and adenylate cyclase activating properties. 
Med Res Rev 3, 201-219 (1983). 
39 Namkung, W., Finkbeiner, W. E. & Verkman, A. S. CFTR-adenylyl 
cyclase I association responsible for UTP activation of CFTR in well-
differentiated primary human bronchial cell cultures. Mol Biol Cell 21, 
2639-2648, doi:10.1091/mbc.E09-12-1004 (2010). 
27 
 
40 Moessinger, A. C., Harding, R., Adamson, T. M., Singh, M. & Kiu, G. T. 
Role of lung fluid volume in growth and maturation of the fetal sheep 
lung. J Clin Invest 86, 1270-1277, doi:10.1172/JCI114834 (1990). 
41 Carmel, J. A., Friedman, F. & Adams, F. H. Fetal Tracheal Ligation and 
Lung Development. Am J Dis Child 109, 452-456 (1965). 
42 Lanman, J. T., Schaffer, A., Castella.R, Ogawa, Y. & Herod, L. 
Distensibility of Fetal Lung with Fluid in Sheep. Pediatr Res 5, 586-&, 
doi:Doi 10.1203/00006450-197111000-00002 (1971). 
43 McCray, P. B., Jr., Bettencourt, J. D. & Bastacky, J. Secretion of lung fluid 
by the developing fetal rat alveolar epithelium in organ culture. Am J 
Respir Cell Mol Biol 6, 609-616, doi:10.1165/ajrcmb/6.6.609 (1992). 
44 Walters, D. V. & Olver, R. E. Liquids in the lung. Respir Physiol Neurobiol 
159, 245-246, doi:10.1016/j.resp.2007.10.003 (2007). 
45 Gallos, G. et al. Functional expression of the TMEM16 family of 
calcium-activated chloride channels in airway smooth muscle. Am J 
Physiol Lung Cell Mol Physiol 305, L625-634, 
doi:10.1152/ajplung.00068.2013 (2013). 
46 Wallace, H. L., Connell, M. G., Losty, P. D., Jesudason, E. C. & Southern, 
K. W. Embryonic lung growth is normal in a cftr-knockout mouse 
model. Exp Lung Res 34, 717-727, doi:10.1080/01902140802389719 
(2008). 
47 Larson, J. E. & Cohen, J. C. Developmental paradigm for early features 
of cystic fibrosis. Pediatr Pulmonol 40, 371-377, 
doi:10.1002/ppul.20169 (2005). 
48 Long, F. R., Williams, R. S. & Castile, R. G. Structural airway 
abnormalities in infants and young children with cystic fibrosis. J 
Pediatr 144, 154-161, doi:10.1016/j.jpeds.2003.09.026 (2004). 
49 Broackes-Carter, F. C. et al. Temporal regulation of CFTR expression 
during ovine lung development: implications for CF gene therapy. Hum 
Mol Genet 11, 125-131 (2002). 
50 Tizzano, E. F., Chitayat, D. & Buchwald, M. Cell-specific localization of 
CFTR mRNA shows developmentally regulated expression in human 
fetal tissues. Hum Mol Genet 2, 219-224 (1993). 
51 Schwiebert, E. M., Flotte, T., Cutting, G. R. & Guggino, W. B. Both CFTR 
and outwardly rectifying chloride channels contribute to cAMP-
stimulated whole cell chloride currents. Am J Physiol 266, C1464-1477 
(1994). 
52 Scott-Ward, T. S. et al. Chimeric constructs endow the human CFTR Cl- 
channel with the gating behavior of murine CFTR. Proc Natl Acad Sci U 
S A 104, 16365-16370, doi:10.1073/pnas.0701562104 (2007). 
53 Lansdell, K. A. et al. Comparison of the gating behaviour of human and 
murine cystic fibrosis transmembrane conductance regulator Cl- 
28 
 
channels expressed in mammalian cells. J Physiol 508 ( Pt 2), 379-392 
(1998). 
54 Brennan, S. C. & Conigrave, A. D. Regulation of cellular signal 
transduction pathways by the extracellular calcium-sensing receptor. 
Curr Pharm Biotechnol 10, 270-281 (2009). 
55 Gadsby, D. C. & Nairn, A. C. Control of CFTR channel gating by 
phosphorylation and nucleotide hydrolysis. Physiol Rev 79, S77-S107 
(1999). 
56 Xie, R. et al. Molecular mechanisms of calcium-sensing receptor-
mediated calcium signaling in the modulation of epithelial ion 
transport and bicarbonate secretion. J Biol Chem 289, 34642-34653, 
doi:10.1074/jbc.M114.592774 (2014). 
57 Sobonya, R. E. & Taussig, L. M. Quantitative aspects of lung pathology 
in cystic fibrosis. Am Rev Respir Dis 134, 290-295 (1986). 
58 Hudak, J. J., Killeen, E., Chandran, A., Cohen, J. C. & Larson, J. E. Adult 
onset lung disease following transient disruption of fetal stretch-
induced differentiation. Respir Res 10, 34, doi:10.1186/1465-9921-
10-34 (2009). 
59 Cohen, J. C. & Larson, J. E. Pathophysiologic consequences following 
inhibition of a CFTR-dependent developmental cascade in the lung. 
BMC Dev Biol 5, 2, doi:10.1186/1471-213X-5-2 (2005). 
60 Cohen, J. C. & Larson, J. E. Cystic fibrosis transmembrane conductance 
regulator (CFTR) dependent cytoskeletal tension during lung 
organogenesis. Dev Dyn 235, 2736-2748, doi:10.1002/dvdy.20912 
(2006). 
61 Zhang, W. K. et al. Mechanosensitive gating of CFTR. Nat Cell Biol 12, 
507-512, doi:10.1038/ncb2053 (2010). 
62 Demedts, M. et al. A new missense mutation in the CASR gene in 
familial interstitial lung disease with hypocalciuric hypercalcemia and 
defective granulocyte function. Am J Respir Crit Care Med 177, 558-
559, doi:10.1164/ajrccm.177.5.558 (2008). 
63 Hu, J. et al. Autosomal dominant hypocalcemia in monozygotic twins 
caused by a de novo germline mutation near the amino-terminus of 
the human calcium receptor. J Bone Miner Res 19, 578-586, 
doi:10.1359/JBMR.040106 (2004). 
64 Fox, L. et al. Neonatal hyperparathyroidism and pamidronate therapy 
in an extremely premature infant. Pediatrics 120, e1350-1354, 
doi:10.1542/peds.2006-3209 (2007). 
65 Auwerx, J., Boogaerts, M., Ceuppens, J. L. & Demedts, M. Defective host 
defence mechanisms in a family with hypocalciuric hypercalcaemia 
and coexisting interstitial lung disease. Clinical and experimental 
immunology 62, 57-64 (1985). 
29 
 
66 Auwerx, J., Demedts, M., Bouillon, R. & Desmet, J. Coexistence of 
hypocalciuric hypercalcaemia and interstitial lung disease in a family: 
a cross-sectional study. European journal of clinical investigation 15, 
6-14 (1985). 
67 Ruano, R. et al. A randomized controlled trial of fetal endoscopic 
tracheal occlusion versus postnatal management of severe isolated 
congenital diaphragmatic hernia. Ultrasound Obstet Gynecol 39, 20-27, 
doi:10.1002/uog.10142 (2012). 
 
 
  
30 
 
Figure Legends 
Figure 1: Expression of chloride channels in the developing mouse lungs and human fetal 
lungs  
Paraffin-embedded, 5 µm-thick sections from E12.5 mouse (left panel) and week 9 - 11 human 
fetal lungs (right panel) were dewaxed and used for immunohistochemistry. Expression of the 
Ca2+-activated chloride channels TMEM16A, bestrophin-1 and CFTR were visualised using 
DAB (brown straining) in the lung epithelium. Sections were counterstained with Harris’ 
hematoxylin (blue staining). Negative controls were carried out in serial sections form the same 
lungs by substituting the primary antibody with an isotype control (inset). Block arrows show 
apical expression in the epithelium, arrowheads show basolateral expression and open arrows 
show expression in the mesenchyme. Scale bar = 100 µm. 
 
Figure 2: CaSR activation drives fluid secretion in fetal mouse and human lungs 
A. E12.5 lungs were cultured for 48 hours in the presence of medium containing either 1.05 
mM, 1.05 mM Ca2+o + the calcimimetic NPS-R568 or 1.05 mM Ca2+o + NPS-R568 + the CFTR 
blocker, Inh-172, before measurement of transluminal potential differences were carried out. 
Pharmacological CaSR activation almost doubled the PD from 100 ± 13% to 184 ± 19%, effect 
which was completely abolished by Inh-172. Data were pooled from 3-4 separate isolations, n 
= 9, for all conditions and are presented as mean (as a percentage of 1.05 mM Ca2+o control) ± 
SEM. ** p < 0.01, one-way ANOVA with Tukey post-test.  
B. Human lung rudiments were separated into two halves and then kept in culture for 72 h in 
medium containing either 1.05 mM Ca2+o in the presence or absence of 100 nM NPS-R58 (n = 
4), or 1.05 mM Ca2+o + 100 nM NPS-R568 (n = 4) in the presence or absence of 10 µM Inh-
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172. Culturing human fetal lungs rudiments in the presence of 1.05 mM Ca2+o + 100 nM NPS-
R568 induced an increase in transluminal potential difference compared to its paired lung half 
cultured in 1.05 mM Ca2+o alone. Furthermore, culturing fetal lung halves in the presence of 
medium containing 1.05 mM Ca2+o + 100 nM NPS-R568 + 10 µM Inh-172 decreased 
transluminal potential difference in comparison to its paired 1.05 mM Ca2+o + 100 nM NPS-
R568 lung half. Data are presented as mean difference from 1.05 mM Ca2+o + 100 nM R568 ± 
SEM. ** p < 0.01, paired t-test.  
C. CaSR and CFTR are co-localised in the human fetal lung epithelium. Week 10 gestation 
human fetal lungs were obtained from maternal donors. Sections from ethically consented week 
10 human fetal lungs were incubated with anti-CFTR (1:200) or anti-CaSR antibodies (1:200) 
and immunoreactivities were detected using Alexa Fluor 594 goat anti-rabbit secondary 
antibodies (1:200). Staining indicates that both CFTR and CaSR are present in the columnar 
and cuboidal epithelium cells of the primitive airways of human fetal lung. 
 
Figure 3: Fetal hypercalcaemia drives fluid secretion via activation of CFTR in the fetal 
human, but not mouse lung 
A. Inh-172 is a specific inhibitor for the CFTR channel. E12.5 lungs were cultured for 48 hours 
in the presence of medium containing 1.70 mM Ca2+o with or without Inh-172, before 
measurements of transepithelial potential differences were carried out. Culturing E12.5 mouse 
lungs in the presence of Inh-172 did not significantly alter transepithelial potential differences 
in lungs cultured in medium containing 1.70 mM Ca2+o. 
B. Human lung rudiments were separated into two halves and then kept in culture for 72 h in 
medium containing either 1.05 mM or 1.70 mM Ca2+o in the presence or absence of the CFTR 
32 
 
inhibitor, Inh-172. Culturing human lung rudiments in medium containing 1.70 mM Ca2+o 
induced an increase in transluminal potential difference that was inhibited by Inh-172. Data are 
pooled from 4 - 6 different lungs for all conditions. Data are presented as mean difference from 
1.70 mM Ca2+o ± SEM. ** p < 0.01, *** p < 0.001, paired t-test. 
 
Figure 4: CaSR activation leads to opening of CFTR: involvement of a calcium-activated 
adenylate cyclase 
A. Fischer Rat Thyroid FRT cells, which endogenously express the CaSR, were engineered to 
express the CFTR channel and a halide-sensitive YFP as an indicator of channel opening. FRT 
cells were fixed with 4% paraformaldehyde before undergoing CaSR immunostaining. Primary 
antibody binding was detected using DAB (brown straining, right panel). Sections were 
counterstained with Harris’ hematoxylin (blue staining). Negative controls were carried out 
through the substitution of the primary antibody with an isotype control (left panel). Scale bar 
= 1000 µm. 
B. FRT cells were pre-incubated for at least 2 min with NPS-R568 (1 µM) in the presence or 
absence of either the CFTR specific inhibitor, Inh-172 (10 µM) or the adenylate cyclase 
inhibitor, MDL-12330A (25 µM). 20 µM forskolin was used as a positive control, and pre-
incubation with Dulbecco’s PBS was used as the time control. After 2 min the cell are perfused 
with iodide-rich Dulbecco’s PBS and the fluorescence of the halide-sensitive YFP is quenched 
at a rate dependent upon the halide permeability of the cell and therefore the activity of anion 
channels or transporters. The calcimimetic R568 quenched YFP fluorescence, demonstrating 
that CaSR activation in FRT cells leads to increased halide permeability of the cell. Inhibition 
of adenylate cyclase by MDL-12330A or CFTR by Inh-172 brought YFP quenching to levels 
similar to that of the time control – demonstrating that the increased halide permeability was 
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due to activation of both adenylate cyclase and CFTR. B, shows average traces of YFP 
quenching (± SD) over time from N = 6 – 13 separate experiments (n = 48 – 232 cells). C, 
shows quantification of YFP quenching as a % of baseline after three minutes. (N = 6 – 13).  
 
Figure 5: Proposed model for CaSR-mediated increase in fetal lung fluid secretion 
In both the mouse and human activation of the CaSR via the calcimimetic NPS R-568 leads to 
an increase in cytosolic Ca2+ through activation of the PI-PLC pathway and release of Ca2+ 
from intracellular stores. This rise in cytosolic calcium leads to an increase in intracellular 
cAMP level via a Ca2+-stimulated adenylate cyclase (AC1), and in turn activation of the cAMP-
dependent enzyme protein kinase A (PKA). Phosphorylation of the CFTR’s regulatory ‘R’-
domain by PKA allows opening of the channel and conductance of Cl- ions through the 
channel. A similar pathway also appears to be in place in response to fetal hypercalcemia in 
the human fetal lung, however this is not the case in the mouse where as yet unknown pathway, 
not involving an apical CFTR channel, appears to induce this increase in fluid secretion. 
